Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population

Won Suk Choi, Ji Yun Noh, Yu Bin Seo, Ji Hyeon Baek, Jacob Lee, Joon Young Song, Dae Won Park, Jin Soo Lee, Hee Jin Cheong, Woo Joo Kim

Research output: Contribution to journalArticle

Abstract

We evaluated the effectiveness of the 2010-2011 seasonal influenza vaccine for preventing laboratory-confirmed influenza in a South Korean population. A retrospective case-control study was conducted among patients who visited selected hospitals from September 2010 to May 2011. A total of 483 laboratory-confirmed influenza patients were included in the analysis as case subjects. For each case patient, two types of control patients were chosen at a ratio of 1:1:1, and 966 control subjects were selected. Vaccine effectiveness (VE) was defined as 100 x (1 - odds ratio for influenza in vaccinated versus nonvaccinated persons). The VE of the 2010-2011 seasonal influenza vaccine was 49.5% to 45.8% for both influenza A and B viruses and 50.8% to 47.2% for influenza A virus, according to the control type. The age-specific adjusted VE was 50.8% to 46.5% among subjects aged 19 to 49 years and 58.7% to 63.3% among those aged 50 to 64 years, according to the control type. Statistically significant VE was not found among those aged ≥65 years or against influenza B virus. The 2010-2011 seasonal influenza vaccine was effective for preventing laboratory-confirmed influenza, especially for influenza A virus, in a South Korean population. Evidence of the effectiveness of the influenza vaccine in older adults or against influenza B virus was not found.

Original languageEnglish
Pages (from-to)835-841
Number of pages7
JournalClinical and Vaccine Immunology
Volume20
Issue number6
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Influenza Vaccines
Virus Diseases
Influenza B virus
Orthomyxoviridae
Viruses
Human Influenza
Case-Control Studies
Influenza A virus
Vaccines
Population
Odds Ratio

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this

@article{dc477248096346f5a74f0a21583b0876,
title = "Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population",
abstract = "We evaluated the effectiveness of the 2010-2011 seasonal influenza vaccine for preventing laboratory-confirmed influenza in a South Korean population. A retrospective case-control study was conducted among patients who visited selected hospitals from September 2010 to May 2011. A total of 483 laboratory-confirmed influenza patients were included in the analysis as case subjects. For each case patient, two types of control patients were chosen at a ratio of 1:1:1, and 966 control subjects were selected. Vaccine effectiveness (VE) was defined as 100 x (1 - odds ratio for influenza in vaccinated versus nonvaccinated persons). The VE of the 2010-2011 seasonal influenza vaccine was 49.5{\%} to 45.8{\%} for both influenza A and B viruses and 50.8{\%} to 47.2{\%} for influenza A virus, according to the control type. The age-specific adjusted VE was 50.8{\%} to 46.5{\%} among subjects aged 19 to 49 years and 58.7{\%} to 63.3{\%} among those aged 50 to 64 years, according to the control type. Statistically significant VE was not found among those aged ≥65 years or against influenza B virus. The 2010-2011 seasonal influenza vaccine was effective for preventing laboratory-confirmed influenza, especially for influenza A virus, in a South Korean population. Evidence of the effectiveness of the influenza vaccine in older adults or against influenza B virus was not found.",
author = "Choi, {Won Suk} and Noh, {Ji Yun} and Seo, {Yu Bin} and Baek, {Ji Hyeon} and Jacob Lee and Song, {Joon Young} and Park, {Dae Won} and Lee, {Jin Soo} and Cheong, {Hee Jin} and Kim, {Woo Joo}",
year = "2013",
month = "6",
day = "1",
doi = "10.1128/CVI.00009-13",
language = "English",
volume = "20",
pages = "835--841",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population

AU - Choi, Won Suk

AU - Noh, Ji Yun

AU - Seo, Yu Bin

AU - Baek, Ji Hyeon

AU - Lee, Jacob

AU - Song, Joon Young

AU - Park, Dae Won

AU - Lee, Jin Soo

AU - Cheong, Hee Jin

AU - Kim, Woo Joo

PY - 2013/6/1

Y1 - 2013/6/1

N2 - We evaluated the effectiveness of the 2010-2011 seasonal influenza vaccine for preventing laboratory-confirmed influenza in a South Korean population. A retrospective case-control study was conducted among patients who visited selected hospitals from September 2010 to May 2011. A total of 483 laboratory-confirmed influenza patients were included in the analysis as case subjects. For each case patient, two types of control patients were chosen at a ratio of 1:1:1, and 966 control subjects were selected. Vaccine effectiveness (VE) was defined as 100 x (1 - odds ratio for influenza in vaccinated versus nonvaccinated persons). The VE of the 2010-2011 seasonal influenza vaccine was 49.5% to 45.8% for both influenza A and B viruses and 50.8% to 47.2% for influenza A virus, according to the control type. The age-specific adjusted VE was 50.8% to 46.5% among subjects aged 19 to 49 years and 58.7% to 63.3% among those aged 50 to 64 years, according to the control type. Statistically significant VE was not found among those aged ≥65 years or against influenza B virus. The 2010-2011 seasonal influenza vaccine was effective for preventing laboratory-confirmed influenza, especially for influenza A virus, in a South Korean population. Evidence of the effectiveness of the influenza vaccine in older adults or against influenza B virus was not found.

AB - We evaluated the effectiveness of the 2010-2011 seasonal influenza vaccine for preventing laboratory-confirmed influenza in a South Korean population. A retrospective case-control study was conducted among patients who visited selected hospitals from September 2010 to May 2011. A total of 483 laboratory-confirmed influenza patients were included in the analysis as case subjects. For each case patient, two types of control patients were chosen at a ratio of 1:1:1, and 966 control subjects were selected. Vaccine effectiveness (VE) was defined as 100 x (1 - odds ratio for influenza in vaccinated versus nonvaccinated persons). The VE of the 2010-2011 seasonal influenza vaccine was 49.5% to 45.8% for both influenza A and B viruses and 50.8% to 47.2% for influenza A virus, according to the control type. The age-specific adjusted VE was 50.8% to 46.5% among subjects aged 19 to 49 years and 58.7% to 63.3% among those aged 50 to 64 years, according to the control type. Statistically significant VE was not found among those aged ≥65 years or against influenza B virus. The 2010-2011 seasonal influenza vaccine was effective for preventing laboratory-confirmed influenza, especially for influenza A virus, in a South Korean population. Evidence of the effectiveness of the influenza vaccine in older adults or against influenza B virus was not found.

UR - http://www.scopus.com/inward/record.url?scp=84878275842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878275842&partnerID=8YFLogxK

U2 - 10.1128/CVI.00009-13

DO - 10.1128/CVI.00009-13

M3 - Article

VL - 20

SP - 835

EP - 841

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 6

ER -